IVD Reagents Market Forecast to 2029: Rising Genetic Testing Adoption Accelerates Market for Oligonucleotide-Based Reagents Worldwide
IVD Reagents Propel Precision Medicine Forward IVD Reagents Market IVD Reagents Market Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) ...
France8d
IVD and Blessing CEO causes buzz as they tattoo each other’s names on their necks
Controversial relationship therapist, Blessing CEO and her lover IVD have caused a stir after they tattooed each other's ...
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow ...
NIT Rourkela Develops Cutting-Edge Traffic Management Solution Using Deep Learning Models
The developed AI-based vehicle detection model and tool have shown enhanced accuracy in traffic management, outperforming ...
360dx4d
Medix Biochemica Acquires Candor Bioscience
Medix said the acquisition adds to its portfolio of raw materials used for in vitro diagnostics development and improves its ability to support immunoassay developers.
Erba Transasia group introduces advanced haematology analyzer in Telangana and Andhra Pradesh
Erba Transasia Group, India’s No. 1 In-vitro Diagnostic (IVD) Company and among the leading global IVD players focused on ...
NIT Rourkela develops traffic management solution using deep learning models
NIT Rourkela researchers develop AI-based vehicle detection model to improve traffic management in developing countries.
Morningstar13d
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences ...
Stockhouse13d
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., ...
Business Wire13d
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal ...